Skip to content
Home/Companies/HealthTech/Huma Therapeutics

Huma Therapeutics

HealthTech·United Kingdom·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Huma Therapeutics?

Huma Therapeutics is currently owned by HAT SGR through HAT Technology Fund 4 (2017 vintage), since 2021.

Hand-verified · updated 2026-07-23

HAT SGR
Investor
HAT SGR
HAT Technology Fund 4 · 2017 · Growth

Key facts

HQUnited Kingdom
SectorHealthTech
StatusActive

More from HAT Technology Fund 4

Other portfolio companies in the same fund.

Texor
Texor
Active
IT ServicesItaly· 2024
Platum
Platum
Active
MobilityItaly· 2022
Burke & Burke
Burke & Burke
Exited 2023
HealthcareItaly· 2021
to
Luisa Via Roma
Active
E-commerceItaly· 2021
Advice Group
Advice Group
Exited 2021
AdTechItaly· 2019
to
Marval
Exited 2024
IndustrialsItaly· 2018
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track Huma Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Huma Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue